RS51300B - Ciklopeptidni derivati sa anti-integrinskom aktivnošću - Google Patents

Ciklopeptidni derivati sa anti-integrinskom aktivnošću

Info

Publication number
RS51300B
RS51300B RSP-2010/0231A RSP20100231A RS51300B RS 51300 B RS51300 B RS 51300B RS P20100231 A RSP20100231 A RS P20100231A RS 51300 B RS51300 B RS 51300B
Authority
RS
Serbia
Prior art keywords
phe
group
asp
arg
gly
Prior art date
Application number
RSP-2010/0231A
Other languages
English (en)
Serbian (sr)
Inventor
Sergio Penco
Loredana Vesci
Claudio Pisano
Alma Dal Pozzo
Giuseppe Giannini
Maria Ornella Tinti
Hong Ni Ming
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of RS51300B publication Critical patent/RS51300B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RSP-2010/0231A 2004-05-13 2005-05-04 Ciklopeptidni derivati sa anti-integrinskom aktivnošću RS51300B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000239A ITRM20040239A1 (it) 2004-05-13 2004-05-13 Derivati ciclopeptidici ad attivita' antintegrine.
PCT/IT2005/000262 WO2005111064A1 (en) 2004-05-13 2005-05-04 Cyclopeptide derivatives with anti-integrin activity

Publications (1)

Publication Number Publication Date
RS51300B true RS51300B (sr) 2010-12-31

Family

ID=34968013

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2010/0231A RS51300B (sr) 2004-05-13 2005-05-04 Ciklopeptidni derivati sa anti-integrinskom aktivnošću

Country Status (23)

Country Link
US (1) US20070178045A1 (cg-RX-API-DMAC7.html)
EP (1) EP1751176B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008500971A (cg-RX-API-DMAC7.html)
KR (1) KR20070012524A (cg-RX-API-DMAC7.html)
CN (1) CN1953990A (cg-RX-API-DMAC7.html)
AR (1) AR048957A1 (cg-RX-API-DMAC7.html)
AT (1) ATE460426T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005243418A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510985A (cg-RX-API-DMAC7.html)
CA (1) CA2562576A1 (cg-RX-API-DMAC7.html)
CY (1) CY1110039T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005019876D1 (cg-RX-API-DMAC7.html)
DK (1) DK1751176T3 (cg-RX-API-DMAC7.html)
ES (1) ES2340862T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20100301T1 (cg-RX-API-DMAC7.html)
IT (1) ITRM20040239A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06012887A (cg-RX-API-DMAC7.html)
PL (1) PL1751176T3 (cg-RX-API-DMAC7.html)
PT (1) PT1751176E (cg-RX-API-DMAC7.html)
RS (1) RS51300B (cg-RX-API-DMAC7.html)
SI (1) SI1751176T1 (cg-RX-API-DMAC7.html)
TW (1) TW200606178A (cg-RX-API-DMAC7.html)
WO (1) WO2005111064A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1996208B1 (en) * 2006-02-09 2013-09-25 Belrose Pharma Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
EP1961759A1 (en) * 2007-02-21 2008-08-27 Universita'degli Studi Di Milano Integrin targeted cyclopeptide ligands, their preparation and use
TWI474819B (zh) * 2012-05-15 2015-03-01 Univ Nat Cheng Kung 調控物及含有該調控物之醫藥組合物
US20160017041A1 (en) * 2013-03-15 2016-01-21 Biogen Ma Inc. Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies
CN103588863B (zh) * 2013-11-15 2016-08-17 苏州强耀生物科技有限公司 Rgd环肽合成制备工艺
WO2022183360A1 (en) * 2021-03-02 2022-09-09 Tsao Yeou Ping Short synthetic peptide and their uses for treating dry eye disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
US6027711A (en) * 1995-06-07 2000-02-22 Rhomed Incorporated Structurally determined metallo-constructs and applications
DE19725368A1 (de) * 1997-06-16 1998-12-17 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren und deren Verwendung für bildgebende Verfahren
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.

Also Published As

Publication number Publication date
HRP20100301T1 (hr) 2010-06-30
AU2005243418A1 (en) 2005-11-24
KR20070012524A (ko) 2007-01-25
PL1751176T3 (pl) 2010-08-31
DE602005019876D1 (de) 2010-04-22
JP2008500971A (ja) 2008-01-17
TW200606178A (en) 2006-02-16
DK1751176T3 (da) 2010-06-14
CA2562576A1 (en) 2005-11-24
ITRM20040239A1 (it) 2004-08-13
CY1110039T1 (el) 2012-05-23
EP1751176A1 (en) 2007-02-14
EP1751176B1 (en) 2010-03-10
MXPA06012887A (es) 2007-02-15
SI1751176T1 (sl) 2010-06-30
PT1751176E (pt) 2010-05-12
ATE460426T1 (de) 2010-03-15
ES2340862T3 (es) 2010-06-10
WO2005111064A8 (en) 2006-02-09
CN1953990A (zh) 2007-04-25
WO2005111064A1 (en) 2005-11-24
US20070178045A1 (en) 2007-08-02
BRPI0510985A (pt) 2007-12-04
AR048957A1 (es) 2006-06-14

Similar Documents

Publication Publication Date Title
EP1753776B1 (en) Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
RS51300B (sr) Ciklopeptidni derivati sa anti-integrinskom aktivnošću
WO2015026251A1 (en) Novel peptidomimetics with antiangiogenic activity
SK62998A3 (en) New lh-rh antagonists with improved effectiveness
US20070232639A1 (en) Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
US7589099B2 (en) 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
KR20050026543A (ko) 항-인테그린 활성을 갖는 플루오로알킬사이클로펩티드유도체
HK1104045A (en) Cyclopeptide derivatives with anti-integrin activity
WO2004005328A2 (en) Peptidomimetic compound useful as inhibitor of integrins
KR20070022292A (ko) 인테그린 길항물질과 20 번 위치에서 공액된 캄토테신유도체
HK1107005A (en) Camptothecin derivatives conjugated in position 20 with integrin antagonists
KR20070022290A (ko) 인테그린 길항물질과 20 번 위치에서 공액된7-티-부톡시이미노메틸캄토테신
HK1104047A (en) Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents